Dry ice Dewar for Advanced Therapy Medicinal Products

CSafe, a global provider of end-to-end cold chain shipping solutions for the pharmaceutical industry, launches the CGT Ultra D – a multi-use, dry ice dewar built to meet the evolving needs of advanced therapy medicinal products (ATMPs). It maintains temperatures below -70C for an industry-leading 37+ days.

Patrick Schafer, CEO of CSafe, commented, “CSafe is committed to supporting the secure and sustainable transport of cell & gene therapies. As emerging ATMPs mature and scale, CGT organizations will need a partner to support them along their commercialization journey. CSafe has the global footprint, proven quality and industry expertise to help ramp up the distribution of life-saving therapies.”

The launch of the CGT Ultra D and CGT Cryo S marks a significant milestone in completing CSafe’s comprehensive suite of dewars, part of its CGT portfolio. These have been designed for performance to ensure coverage of a full spectrum of temperature ranges and the efficacy of cell & gene therapies. The dewars come equipped with TracSafe RLT data loggers, which provide real-time GPS location and conditional data via CSafe Connect, CSafe’s cloud-based portal.

Emilio Frattaruolo, Vice President of Cell & Gene Therapies at CSafe, comments: “We’re excited to unveil the CGT Ultra D and preview the CGT Cryo S at Meeting on the Mesa next week. The launch of these products complete CSafe’s portfolio of dewars, offering customers market-leading thermal performance and real-time data logging capabilities.”

Earlier this year, CSafe launched the CGT Cryo M, a liquid nitrogen, multi-use dewar, which is available in 4 and 10 liters, and maintains temperatures below -150C for over 10 days. The product was unveiled at LogiPharma EU, in Lyon, France.

For a wider range of sizes, CSafe’s dry ice CGT Ultra parcel shipper is available in payload sizes ranging from 2 to 56 liters and can sustain temperatures below -70C for 96 and 120 hours, respectively. CSafe’s full CGT product range is qualified against rigorous ISTA 7D testing standards and achieves industry-leading performance.